İNVAZİV ASPERGİLLOZUN ÖN TANIMINDA GALAKTOMANNAN ANTİJENİNİ BELİRLEMENİN YERİ VE ÖNEMİ

1. Maertens J, Theunissen K, Boogaerts M. Invasive
aspergillosis. Focus on new approaches and new
therapeutic agents. Curr Med Chem-Anti-Infective
Agents 2002; 1: 65-81.
2. Donnelly JP. Febrile neutropenia: antifungal prophylaxis.
Int J Antimicrob Agents 2000; 16: 127-130.
3. Lin SJ, Schranz J, Teut SM. Aspergillosis case-fatality
rate: systematic review of the literature. Clin Infect Dis
2001; 32: 358-366.
4. Liao R. Diagnosis of invasive aspergillosis by the
detection of galactomannan. www.pathology.wust.edu/
labmed/ Abstracts/03_20_03 abstr.html
Temmuz-Eylül 2005 GALAKTOMANNAN BELİRLENMESİ; KANTARCIOĞLU VE YÜCEL
163
5. Albelda SM, Talbot GH, Gerson SL. Role of fiberoptic
bronchoscopy in the diagnosis of invasive pulmonary
aspergillosis in patients with acute leukemia.Am J Med
1984; 76: 1027-1034.
6. Kahn FW, Jones JM, England DM. The role of
bronchoalveolar lavage in the diagnosis of invasive
pulmonary aspergillosis. Am J Clin Pathol 1986; 86: 518-
523.
7. Saito H, Anaissie EJ, Morice RC. Bronchoalveolar lavage
in the diagnosis of pulmonary infiltrates in patients with
acute leukemia. Chest 1988; 94: 745-749.
8. Levy H, Horak DA, Tegtmeier BR. The value of
bronchoalveolar lavage and bronchial washings in the
diagnosis of invasive pulmonary aspergillosis.
Respiratory Medicine 1992; 86: 243-248.
9. Pagano L, Pagliari G, Basso A. The role of
bronchoalveolar lavage in the microbiological diagnosis
of pneumonia in patients with haematological
malignancies. Ann Medicine 1997; 29: 535-540.
10. Kantarcioglu A S, Erturan S, Bagdatli Y, Yaman M.
Investigation of fungi in bronchoscopically acquired
specimens of patients with pulmonary disoders. 14th
ECCMID Clin Microbiol Infect, 2004; 10 (Suppl 1):
633.
11. Maschmeyer G, Beinert T, Buchheidt D, Einsele H,
Heussel CP, Kiehl M, Loren J. Infectious Diseases
Working Party (AGIHO) of the German Society of
Hematology and Oncology (DGHO). Ann Hematol 2003;
82 (Suppl 2): S118-126.
12. Donnely JP. Therapy of fungal infections-Strategies for
managing invasive aspergillosis. 5th International
Symposium on Febrile Neutropenia, (Brussels, December
12/14, 2001).
www.febrilneutropenia.org/abstract/e_depau.htm
13. Donnelly, J. P. (2000). A strategy for managing fungal
infections in haematopoietic stem cell transplantation.
Transpl Infect Dis 2: 88-95.
14. Stevens DA. Diagnosis of fungal infections: current
status. J Antimicrob Chemother 2002; 49 (Suppl 1): 11-
19.
15. Ascioglu S, Rex JH, de Pauw B, Bennet JE, Bille J,
Crokaert F, Denning DW, Donnelly JP, Edwards JE,
Erjavec Z, Fiere D, Lortholary O, Maertens J, Meis JF,
Patterson TF, Ritter J, Selleslag D, Shah PM, Walsh TJ.
Invasive fungal Infections Cooperative Group of the
European Organization for Research and Treatment of
Cancer; Mycoses Study Group of the National Institute of
Allergy and Infectious Disease. Defining opportunistic
invasive fungal infections in immunocompromised
patients with cancer and hematopoietic stem cell
transplants: an international consensus. Clin Infect Dis
2002; 34: 7-14.
16. Hebart H, Loffler J, Meisner C, Serey F, Schmidt D,
Bohme A, Mart Engel A, Bunje D, Kern WV, Scumacher
U, Kanz L, Einsele H. Early detection of Aspergillus
infection after allogenic stem cell transplantation by
polymerase chain reaction screening. J Infect Dis 2000;
181: 1713-1719.
17. Reiss E, Obayashi T, Orle K, Yoshida M, Zancope-
Olivera RM. Non-culture based diagnostic tests for
mycotic infections. Med Mycol; 38 (Suppl 1): 147-159.
18. Rand KH, Houck H, WolfF M. Detection of candidemia
by polymerase chain reaction. Mol Cell Probes 1994; 8:
215-221.
19. Löffler J. Application of PCR to detect fungi in clinical
specimens. Program and abstract of the Interscience
Conference Antimicrobial Agents Chemotherapy. San
Francisco, CA, September 26-29, 1999. Washington DC,
American Society for Microbiology, 1999, Abstract 491.
20. Loeffler JH, Hebart S, Sepe C, Schumayer C, Klingebiel
T, Einsele II. Detection of PCR-amplified fungal DNA by
using a PCR-ELISA system. Med Mycol 1998; 36: 275-
279.
21. Van Burik JA, Myerson D, Schreckhise RW, Bowden
RA. Panfunfal PCR assay for detection of fungal
infection in human blood specimens. J Clin Microbiol
1998; 36: 1169-1175.
22. Fenelon LE, Hamilton AJ, Figueroa JI, Bartholomev MA,
Allen MH, McCarthy P, Hay RJ. Production of specific
monoclonal antibodies to Aspergillus species and their
use in immunohistochemical identification of
aspergillosis. J Clin Microbiol 1999; 37: 1221-1223.
23. Pasmans HLM, Loosveld OJL, Schouten TC. Invasive
aspergillosis in immunocompromised patients. Findings
on plain film and (HR)CT. Eur J Radiol 1992; 14: 37-40.
24. Kuhlman JE, Fishman EK, Siegelman SS. Invasive
pulmonary aspergillosis in acute leukemia: characteristic
findings on CT, the CT halo sign and the role of CT in
early diagnosis. Radiology 1985; 157: 611-614.
25. Taccone A, Occhi M, Garaventa A. CT of invasive
pulmonary aspergillosis in children with cancer. Pediatric
Radiology 1993; 23: 177-180.
26. Blum U, Windfuhr M, Buitrago-Tellez C. Invasive
pulmonary aspergillosis MRI, CT, and plain radiographic
findings and their contribution for early diagnosis. Chest
1994; 106: 1156-1161
27. Primack SI, Hartman TE, Lee KS. Pulmonary noduls in
the CT halo sign. Radiology 1994; 190: 513-515.
28. Sallustio G, Pagano L, La Barbera EO. Pulmonary
aspergillosis in patients with hematologic malignancies:
clinicoradiologic corelation. Rays 1994; 19: 465-468.
29. Herbrecht R, Denning DW, Patterson TF, Bennett JE,
Greene RE, Oestmann JW, Kern WV, Marr KA, Ribaud
P, Lortholary O, Sylvester R, Rubin RH, Wingard JR,
Stark P, Durand C, Caillot D, Thiel E, Chandrasekar PH,
Hodges MR, Schlamm HT, Troke PF, de Pauw B;
CERRAHPAŞA TIP DERGİSİ Cilt (Sayı) 36 (3)
164
Invasive Fungal Infections Group of the European
Organisation for Research and Treatment of Cancer and
the Global Aspergillus Study Group. Voriconazole
versus amphotericin B for primary therapy of invasive
aspergillosis. N Engl J Med 2002; 347: 408-415.
30. Stynen D, Sarfatti J, Goris A, Prévost MC, Lesourd M,
Kamphuis H, Darras V, Latge JP. Rat monoclonal
antibodies against Aspergillus galactomannan. Infect
Immun 1992; 60: 2237-2245.
31. Haynes K, Rogers TR. Retrospective evaluation of a latex
agglutination test for diagnosis of invasive aspergillosis
in immunocompromised patients. Eur J Clin Microbiol
Infect Dis 1994: 13: 670-674.
32. Hopwood V, Johnson EM, Cornish JM, Foot AB, Evans
EG, Warnock DW. Use of the Pastorex aspergillus
antigen test for the diagnosis of invasive aspergillosis. J
Clin Pathol 1995; 48: 210-213.
33. Verweij PE, Rijs AJ, De Pauw BE, Horrevorts AM,
Hoogkamp-Korstanje JA, Meis JF. Clinical evaluation
and reproducibility of the Pastorex Aspergillus antigen
latex agglutination test for diagnosing invasive
aspergillosis. J Clin Pathol 1995; 48: 474-476.
34. Denning DW, Marinus A, Cohen J, Spence D, Herbrecht
R, Pagano L, Kibber C, Kremery V, Offner F, Cordonier
C, John U, Ellis M, Collette L, Sylvester R. An EORTC
multicenter prospective survey of invasive aspergillosis
haematological patients: diagnosis and therapeutic
outcome. Invasive Fungal Infections Cooperative Group.
J Infect 1998; 2: 173-180.
35. Warnock DW, Foot ABM, Johnson EM,Mitchel SB,
Cornish JM, Oakhill A. Aspergillus antigen latex test for
diagnosis of invasive aspergillosis. Lancet. 1991; 338:
1023-1024.
36. Stynen D, Goris A, Sarfati J, Latgé JP. A new sensitive
sandwich enzyme-linked immunosorbent assay to detect
galactofuran in patients with invasive aspergillosis. J Clin
Microbiol 1995; 33: 497-500.
37. Verweij PE, Erjavec Z, Sluiters W, Goessens W,
Rozenberg-Arska M, Debets-Ossenkopp YJ, Guiot HFL,
Meis JFGM for the Dutch Interuniversity Working Party
for Invasive Mycoses. Detection of Antigen in sera of
patients with invasive aspergillosis: intr- and
interlaboratory reproducibility. J Clin Microbiol 1998;
36: 1612-1616.
38. US Food and Drug Administration 2003 Annual report.
Bringing new products to the market.
http://www.fda.gov/cdrh/annual/fy2003/bringing.html
39. Sulahian A, Tabouret M, Ribaud P, Sarfati J, Gluckman
E, Latge J, Derouin F. Comparison of an enzyme
immunoassay and latex agglutination test for detection of
galactomannan in the diagnosis of invasive aspergillosis.
Eur J Clin Microbiol Infect Dis 1996; 15: 139-145.
40. Wheat LJ. Rapid diagnosis of invasive aspergillosis by
antigen detection. Transplant Infect Dis 2003; 5: 158-
166.
41. Verweij PE, Latgé JP, Rijs AJMM, Melchers WJG, De
Pauw BE, Hoogkamp-Korstanje JAA, Meis JFGM.
Comparison of antigen detection and PCR assay using
bronchoalveolar lavage fluid for diagnosing invasive
pulmonary aspergillosis in patients receiving treatment
for hematological malignancies. J Clin Microbiol 1995;
33: 3150-3.
42. Rohrlich P, Sarfati J, Mariani P, Duval M, Carol A,
Saint-Martin C, Bingen E, Latgé JP, Vilmer E.
Prospective sandwich enzyme linked immunosorbent
assay for serum galactomannan: early predicitve value
and clinical use in invasive aspergillosis. Pediatr Infect
Dis J 1996; 15: 232-7.
43. Maertens J, Verhaegen J, Demuynck H et al. Autopsycontrolled
prospective evaluation of serial screening for
circulating galactomannan by a sandvich enzyme-linked
immunosorbent assay for hematological patients at risk
for invasive aspergillosis. J Clin Microbiol 1999; 37:
3223-3228.
44. Machetti M, Feasi M, Mordini N, Van Lint MT,
Bacigalupo A, Latge JP, Sarfati J, Viscoli C. Comparison
of an enzyme immunoassay and a latex agglutination
system for the diagnosis of invasive aspergillosis in bone
marrow transplant recipients. Bone Marrow Transplant
1998;21: 917-21.
45. Bretagne S, Costa JM, Bart-Delabesse E, Dhedin N,
Rieux C, Cordonnier C. Comparison of serum
galactomannan antigen detection and competitive
polymerase chain reaction for diagnosing invasive
aspergillosis. Clin Infect Dis 1998; 26: 1407-1412.
46. Husain S, Kwak EJ, Obman A, Wagener MM, Kusne S,
Stout JE, R McCourry K, Singh N. Prospective assesment
of Platelia trade mark Aspergillus galactomannan antigen
for the diagnosis of invasive aspergillosis in lung
transplant recipients. Am J Transplant 2004; 4: 796-802.
47. Herbrecht R, Letscher-Bru V, Oprea C, Lioure B, Waller
J, Campos F, Villard O, Liu KL, Natarajan-Ame S, Lutz
P, Dufour P, Bergerat JP, Candolfi E. Aspergillus
galactomannan detection in the diagnosis of invasive
aspergillosis in cancer patients. J Clin Oncol. 2002; 20:
1898-1906.
48. Mennik-Kersten MA, Klont RR, Warris A, Op den Camp
HJ, Verweij PE. Bifidobacterium lipoteichoic acid and
false ELISA reactivity in Aspergillus antigen detection.
Lancet 2004; 363: 325-327.
49. Swanink CMA, Meis JFGM, Rijs AJMM, Donnelly JP,
Verweij PE. Specificity of a sandwich enzyme linked
immunosorbent assay for detecting Aspergillus
galactomannan. J Clin Microbiol 1997; 35: 257-260.
50. Sulahaian A, Touratier S, Ribaud P. False positive test for
aspergillus antigenemia related to concomitant
Temmuz-Eylül 2005 GALAKTOMANNAN BELİRLENMESİ; KANTARCIOĞLU VE YÜCEL
165
administration of piperacillin and tazobactam. N Engl J
Med 2003; 349: 2366-2367.
51. Viscoli C, Machetti M, Cappellano P, Bucci B, Bruzzi P,
Van Lint MT, Bacigalupo A. False-positive
galactomannan platelia Aspergillus test results for
patients receiving piperacillin-tazobactam. Clin Infect Dis
2004; 38: 913-916.
52. Walsh TJ, Shoham S, Petraitiene R, Sein T, Schaufele R,
Kelaher A, Murray H, Mya-San C, Bacher J, Petraitis.
Detection of galactomannan antignemia in patients
receiving piperacillin-tazobactam and correlations
between in vitro, in vivo and clinical properties of the
drug-antigen interaction. J Clin Microbiol 2004; 42:
4744-4748.
53. Adam O, Auperin A, Wilquin F, Bourhis JH, Gachot B,
Chachaty E. Treatment with piperacillin-tazobactam and
false-positive Aspergillus galactomannan antigen test
results for patients with hematological malignancies. Clin
Infect Dis 2004; 38: 917-920.
54. Hamaki T, Kami M, Kanda Y, Miyakoshi S, Ueyama J,
Morinaga S, Mutou Y. False positive results of
Aspergillus enzyme-linked immunosorbent assay in a
patient with chronic graft versus host disease after
allogenic bone marrow transplantation. Bone Marrow
Transplant 2001; 28: 633-634.
55. Ansorg R, van den Boom R, Rath P-M. Detection of
Aspergillus galactomannan antigen in foods and
antibiotics. Mycoses 1997; 40: 353-357.
56. Kappe R, Schulze-Berge A. New cause for false-positive
results with the Pastorex Aspergillus antigen latex
agglutination test. J Clin Microbiol 1993; 31: 2489-2490.
57. Kricka LJ. Human anti-animal antibody interferons in
immunological assays. Clin Chem 1999; 45: 942-956.
58. Dalle F, Lopez J, Caillot D, Cuisenier B, Ecarnot LA,
Dumont L, Bonnin A. False-positive results caused by
cotton swabs in commercial Aspergillus antigen latex
agglutination test. Eur J Clin Infect Dis 2002; 21: 130-
132.
59. Levy H, Horak DA, Tegtmeier BR, Yokota SB, Forman
SJ. Respiratory Medicine 1992; 86: 243-.
60. Hurst SF, Reves GH, McLaughin DW, Reiss E, Morrison
CJ. Comparison of commercial latex agglutination and
sandwich enzyme immunoassays with a competitive
binding inhibition enzyme immunoassay for detection of
antigenemia and antigenuria in a rabbit model of invasive
aspergillosis. Clin Diagn Lab Immunol 2000; 7: 477-485.
61. La Rocco MT, Burget SJ. Fungal infections in the
transplant recipient and laboratory methods for diagnosis.
Rev Iberoam Mycol 1997; 14: 143-146.
62. Anaissie EJ, Kuchar RT, Rex JH, Francesconi A, Kasai
M, Muller FM, Lozano-Chiu M, Summerbell RC,
Dignani MC, Chanock SC, Walsh TJ. Fusariosis
associated with pathogenic Fusarium species
colonization of a hospital water system: a new paradigm
for the epidemiology of opportunistic mold infections.
Clin Infect Dis 2001; 333: 1871-1878.
63. Woo PCY, Chan C-M, Leung ASP, Lau SKP, Che X-Y,
Wong SSY, Cao L, Yuen K-Y. Detection of cell wall
galactomannoprotein Afmp1p in culture supernatants of
Aspergillus fumigatus and in sera of aspergillosis
patients. J Clin Microbiol 2002; 40: 4382-4387.
64. Hayden R, Knapp K, Brandt DA.Detection of Aspergillus
galactomannan in pediatric serum samples a performance
evaluation of the Bio-Rad Platelia Aspergillus EIA,
Imedex Inc., USA. Focus on Fungal Infections 13 (March
19-21, 2003, Maui, Hawaii).
65. Verweij PE, Weemaes CM, Curfs JHAJ, Bretagne S,
Meis JFGM. Failure to detect circulating Aspergillus
markers in a patient with chronic granulomatous disease
and invasive aspergillosis. J Clin Microbiol 2000; 38:
3900-3901.
66. d’Enfert C, Grillot R, Rath PM, Richardson M, Ruechel
R, Ruhnke M, Schmidt A, Verweij P. Meetings 2000:
Focus on Aspergillus and aspergillosis. Mycology
Newsletter 2000; 1: 6-16.
67. Klont RR, Meis JFMG, Verweij P. Clinical assessement
of issues in the diagnosis of invasive aspergillosis. Clin
Microbiol Infect 2001; 7 (Suppl 2): 32-37.
68. Kantarcıoğlu AS, Yücel A, Keskinel İ, Erk M. Olgu
bildirimi: Bir akciğer aspergillozu olgusunun mikoloji
yönünden izlenmesi. Cerr Tıp Fak Derg 2003; 34: 194-
203.
69. Kantarcıoğlu AS, Yücel A. Aspergillus cinsi mantarlar ve
invaziv aspergilloz: mikoloji, patogenez, laboratuvar
tanımı, antifungallere direnç ve duyarlılık deneyleri. Cerr
Tıp Fak Derg 2003; 34: 140-157.
70. Rovira M, Jimenez M, De La Bellacasa JP, Mensa J,
Rafel M, Ortega. M, Almela M, Martinez C, Fernandez-
Aviles F, Martinez JA, Urbano-Ispizua A, Carreras E,
Montserrat E. Detection of Aspergillus galactomannan by
enzyme immunosorbent assay in recipient of allogenic
hematopoietic stem cell transplantation: a prospective
study. Transplantation 2004; 28: 1260-1264.
71. Ulusakarya A, Chachaty E, Vantelon JM, Youssef A,
Tancrede C, Pico J, Borhis JH, Fenaux P, Munck JN.
Surveillance of Aspergillus galactomannan antigenemia
for invasive aspergillosis by enzyme-linked
immunosorbent assay in neutropenic patients treated for
hematological malignancies. Hematol J 2000; 1: 111-116.
72. Kwak EJ, Husain S, Obman A, Meinke L, Stout J, Kusne
S, Wagener MM, Singh N. Efficacy of galactomannan
antigen in the Platelia Aspergillus enzyme immunoassay
for diagnosis of invasive aspergillosis in liver transplant
recipients. J Clin Microbiol 2004; 42: 435-438.
73. Skladny H, Buchreidt D, Baust C, Krieg-Schneider F,
Seifarth W, Leib-Mosch C, Hehlmann R. Specific
detection of Aspergillus species in blood and
CERRAHPAŞA TIP DERGİSİ Cilt (Sayı) 36 (3)
166
bronchoalveolar lavage samples of immunocompromised
patients by two step PCR. J Clin Microbiol 1999; 37:
3865-3871.
74. Becker MJ, Lugtenburg EJ, Cornelissen JJ, Van Der
Schee C, Hoogsteden HC, De Marie S. Galactomannan
detection in computerized tomography-based bronchoalveolar
lavage fluid and serum in hematological patients
at risk for invasive pulmonary aspergillosis. Br J Hematol
2003; 121: 448-457.
75. Pinel C, Fricker-Hidalgo H, Lebeau B, Garban F,
Hamidfar R, Ambroise-Thomas P, Grillot R. Detection of
circulating Aspergillus fumigatus galactomannan: value
and limits of the Platelia test for diagnosing invasive
aspergillosis. J Clin Microbiol. 2003; 41: 2184-6.
76. Caillot D, Casasnovas O, Bernard A, Cauvaillier JF,
Durand C, Cuisenier B, Solary E, Piard F, Petrella T,
Bonnin A, Couillault G, Dumas M, Guy H. Improved
management of invasive aspergillosis in neutropenic
patients using early thoracic computed tomographic scan
and surgery. J Clin Oncol 1997;15: 139-47.
77. Machetti M, Zotti M, Veroni L, Mordini N, van Lint MT,
Bacigalupo A, Paola D, Viscoli C. Antigen detection in
the diagnosis and management of a patient with probable
cerebral aspergillosis treated with voriconazole.
Transplant Infect Dis 2000; 2: 340-344.
78. Viscoli C, Machetti M, Gazzola E, de Maria A, Paola D,
van Lint MT, Gualandi F, Truini M, Bacigalupo A.
Aspergillus galactomannan antigen in the cerebrospinal
fluid of bone marrow transplant recipients with probable
cerebral aspergillosis. J Clin Microbiol 2002; 40: 1496-
1499.
79. Verweij PE, Brinkman K, Kremer HP, Kullberg BJ, Meis
JF. Aspergillus meningitis: diagnosis by non-culture
based microbiological methods and management. J Clin
Microbiol 1999; 37: 1186-1189.
80. Kami M, Ogawa S, Kanda Y, Tanaka Y, Machida U,
Matsumara T, Sakamaki H, Hirai H. Early diagnosis of
central nervous system aspergillosis using polymerase
chain reaction, latex agglutination test and enzyme-linked
immunosorbent assay. Br J Haematol 1999; 106: 536-
537.
81. Salonen J, Lehtonen OP, Terasjarvi MR, Nikoskelainen J.
Aspergillus antigen in serum, urine and bronchoalveolar
lavage specimens of neutropenic patients in relation to
clinical outcome. Scand J Infect Dis 2000; 32: 485-490.